Filter
1601
Text search:
national
drug
authority
Featured
132
524
Language
Document type
921
238
224
96
69
20
18
8
2
2
1
1
Countries
98
76
71
66
47
44
44
42
41
41
35
34
33
32
29
29
26
24
24
22
19
18
17
17
15
11
11
10
10
9
9
8
8
7
6
6
6
6
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
823
87
69
67
48
30
23
Toolboxes
130
119
106
101
61
39
35
31
27
26
26
26
24
23
23
20
19
16
10
9
9
8
8
7
2
WHO/UNICEF/UNFPA joint statement
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
